Home › Endometrial Cancer › NCT07407959

Screening and Staging of Benign vs Malignant Pelvic Abnormalities

Clinical Evidence Generation of AI Enabled Fast, Accurate and Precise Screening and Staging of Benign vs Malignant Pelvic Abnormalities

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Patient over the age of 18
* For prostate group, any patient referred for prostate MR for screening purposes with no prior prostate related treatment or prior biopsy
* For endometriosis group, any patient referred for possible endometriosis evaluation (pre-surgical)

Exclusion Criteria:

* Individuals unable to undergo MRI imaging (MR-conditional or MR-nonconditional devices which would need additional procedures/conditions for scanning, pregnant people, individuals with implanted metal, etc.)
* Patient under the age of 18
* Patient who is unable to consent

About the study

This study evaluates whether newly developed non-FDA approved image processing techniques \[Adaptive Image Reconstruction (AIR Recon) Deep Learning (DL) and Sonic DL\] can provide improved quality and decreased time compared to current scanning techniques.

What is being tested

• Non-Interventional Study (other)

Sponsor: Mayo Clinic · Participants: 60 · Started: Sep 4, 2025

Contact the study team

• Clinical Trials Referral Office · Phone: 855-776-0015
• Bobbie Ott · Phone: 507-293-0922

Official record on ClinicalTrials.gov — NCT07407959

Locations in the U.S.

Conditions

• Endometrial Cancer
• Prostate Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.